CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats

The present study is aimed at investigating the molecular mechanism of C1q/TNF-related protein 9 (CTRP9) and providing a new perspective in arteriovenous shunt-induced pulmonary arterial hypertension (PAH). PAH was established by an arteriovenous shunt placement performed in rats. Adenovirus(Ad)-CTR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hua Guan, Xiaofeng Yang, Tao Shi, Yongjian Zhang, Aoqi Xiang, Yongxin Li
Formato: article
Lenguaje:EN
Publicado: Hindawi-Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/c0b12b00dc544aee863ba4db0bc79ac9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0b12b00dc544aee863ba4db0bc79ac9
record_format dspace
spelling oai:doaj.org-article:c0b12b00dc544aee863ba4db0bc79ac92021-11-22T01:10:16ZCTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats1755-592210.1155/2021/4971300https://doaj.org/article/c0b12b00dc544aee863ba4db0bc79ac92021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/4971300https://doaj.org/toc/1755-5922The present study is aimed at investigating the molecular mechanism of C1q/TNF-related protein 9 (CTRP9) and providing a new perspective in arteriovenous shunt-induced pulmonary arterial hypertension (PAH). PAH was established by an arteriovenous shunt placement performed in rats. Adenovirus(Ad)-CTRP9 and Ad-green fluorescent protein viral particles were injected into the rats through the tail vein. Following 12 weeks, the mean pulmonary arterial pressure (mPAP) and right ventricular systolic pressure (RVSP) were measured and morphological analysis was conducted to confirm the establishment of the PAH model. The systemic elevation of CTRP9 maintained pulmonary vascular homeostasis and protected the rats from dysfunctional and abnormal remodeling. CTRP9 attenuated the pulmonary vascular remodeling in the shunt group by decreasing the mPAP and RVSP, which was associated with suppressed inflammation, apoptosis, and extracellular matrix injury. In addition, CTRP9 dramatically increased the phosphorylation of AKT and p38-MAPK in the lung tissues of shunt-operated animals. These findings suggest a previously unrecognized effect of CTRP9 in pulmonary vascular homeostasis during PAH pathogenesis.Hua GuanXiaofeng YangTao ShiYongjian ZhangAoqi XiangYongxin LiHindawi-WileyarticleTherapeutics. PharmacologyRM1-950Diseases of the circulatory (Cardiovascular) systemRC666-701ENCardiovascular Therapeutics, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Therapeutics. Pharmacology
RM1-950
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Therapeutics. Pharmacology
RM1-950
Diseases of the circulatory (Cardiovascular) system
RC666-701
Hua Guan
Xiaofeng Yang
Tao Shi
Yongjian Zhang
Aoqi Xiang
Yongxin Li
CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
description The present study is aimed at investigating the molecular mechanism of C1q/TNF-related protein 9 (CTRP9) and providing a new perspective in arteriovenous shunt-induced pulmonary arterial hypertension (PAH). PAH was established by an arteriovenous shunt placement performed in rats. Adenovirus(Ad)-CTRP9 and Ad-green fluorescent protein viral particles were injected into the rats through the tail vein. Following 12 weeks, the mean pulmonary arterial pressure (mPAP) and right ventricular systolic pressure (RVSP) were measured and morphological analysis was conducted to confirm the establishment of the PAH model. The systemic elevation of CTRP9 maintained pulmonary vascular homeostasis and protected the rats from dysfunctional and abnormal remodeling. CTRP9 attenuated the pulmonary vascular remodeling in the shunt group by decreasing the mPAP and RVSP, which was associated with suppressed inflammation, apoptosis, and extracellular matrix injury. In addition, CTRP9 dramatically increased the phosphorylation of AKT and p38-MAPK in the lung tissues of shunt-operated animals. These findings suggest a previously unrecognized effect of CTRP9 in pulmonary vascular homeostasis during PAH pathogenesis.
format article
author Hua Guan
Xiaofeng Yang
Tao Shi
Yongjian Zhang
Aoqi Xiang
Yongxin Li
author_facet Hua Guan
Xiaofeng Yang
Tao Shi
Yongjian Zhang
Aoqi Xiang
Yongxin Li
author_sort Hua Guan
title CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
title_short CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
title_full CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
title_fullStr CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
title_full_unstemmed CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
title_sort ctrp9 mitigates the progression of arteriovenous shunt-induced pulmonary artery hypertension in rats
publisher Hindawi-Wiley
publishDate 2021
url https://doaj.org/article/c0b12b00dc544aee863ba4db0bc79ac9
work_keys_str_mv AT huaguan ctrp9mitigatestheprogressionofarteriovenousshuntinducedpulmonaryarteryhypertensioninrats
AT xiaofengyang ctrp9mitigatestheprogressionofarteriovenousshuntinducedpulmonaryarteryhypertensioninrats
AT taoshi ctrp9mitigatestheprogressionofarteriovenousshuntinducedpulmonaryarteryhypertensioninrats
AT yongjianzhang ctrp9mitigatestheprogressionofarteriovenousshuntinducedpulmonaryarteryhypertensioninrats
AT aoqixiang ctrp9mitigatestheprogressionofarteriovenousshuntinducedpulmonaryarteryhypertensioninrats
AT yongxinli ctrp9mitigatestheprogressionofarteriovenousshuntinducedpulmonaryarteryhypertensioninrats
_version_ 1718418366370152448